Day: August 22, 2022

With 7.6% CAGR, Colorectal Cancer Therapeutics Market Size worth USD 16.58 Billion by 2026

Written by Customer Service on August 22, 2022. Posted in Mergers And Acquisitions.

According to Fortune Business Insights, the global Colorectal Cancer Therapeutics Market size is projected to reach USD 16.58 Billion by 2026, at CAGR of 7.6% during forecast period; Rise in Disposable Incomes and Increasing Awareness about Therapeutic Procedures to Help Asia Pacific Witness Rapid Growth Pune, India, Aug. 22, 2022 (GLOBE NEWSWIRE) — The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights™ titled, “Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies,...

Enlivex Announces Second Quarter 2022 Financial Results and Provides a Business Update

Written by Customer Service on August 22, 2022. Posted in Earnings Releases And Operating Results.

Dosed first patient in Phase I/II trial evaluating Allocetra™ combined with chemotherapy in patients with peritoneal metastases arising from solid cancers Received Israeli Ministry of Health approval to initiate a Phase I/II trial evaluating Allocetra™ alone and in combination with a PD1 checkpoint inhibitor in patients with advanced solid tumors. Announced preclinical data in ovarian cancer (in collaboration with Yale Cancer Center) and mesothelioma showing substantial, statistically significant survival benefits when Allocetra™ is combined with PD1 or CTLA4 checkpoint inhibition, respectively Appointed new Vice Chairman of the Board, Dr. Roger J. Pomerantz, who previously served as Worldwide Head of Licensing and Acquisition and Knowledge Management at Merck & Co., Global Head of Infectious Diseases for Johnson & Johnson Pharmaceuticals,...

Bright Green Announces Second Quarter 2022 Financial Update and Milestone Progress

Written by Customer Service on August 22, 2022. Posted in Earnings Releases And Operating Results.

Second Quarter Results and Favorable Liquidity Position Set the Stage for Growth in Fiscal Year 2023 and Beyond GRANTS, N.M., Aug. 22, 2022 (GLOBE NEWSWIRE) — Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or “the Company”), one of few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today reported financial results for the quarter ended June 30, 2022. “This quarter has shown that Bright Green is uniquely positioned to capitalize on a growing market opportunity and deliver on our near and long-term goals as we scale our business,” said Terry Rafih, Bright Green’s Interim Chief Executive Officer and Chairman of the Board. “In May, we completed a direct...

Pineapple Energy Reports Second Quarter 2022 Results

Written by Customer Service on August 22, 2022. Posted in Earnings Releases And Operating Results.

Progress on key initiatives in first full quarter as publicly traded companySolid performance in core Hawaii marketProgress in building infrastructureExploring multiple routes into new market entry MINNETONKA, Minn., Aug. 22, 2022 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (“Pineapple” or the “Company”) (Nasdaq:PEGY), a leading provider of sustainable solar energy and back-up power to households and small businesses, today announced financial results for the second quarter ended June 30, 2022. “Performance in our first full quarter as a public company showed the strength of our strategy and market opportunity,” said Kyle Udseth, Pineapple CEO. “Growth was strong in our core initial market of Hawaii, especially in battery storage where installations were up 53%.” Udseth continued, “We built backlog—and thus customer relationships...

Tornado Global Hydrovacs Reports Second Quarter 2022 Results

Written by Customer Service on August 22, 2022. Posted in Earnings Releases And Operating Results.

Revenue Increased Significantly By 89% Compared To Q2 2021 CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) — Tornado Global Hydrovacs Ltd. (“Tornado” or the “Company”) (TSX-V: TGH; OTCQX: TGHLF) today reported its unaudited financial and operating results for the three months period ended June 30, 2022, with comparisons to the same period last year. The unaudited condensed consolidated financial statements and related management discussion and analysis are available on the Company’s issuer profile in Canada on SEDAR at www.sedar.com, the United States at www.otcmarkets.com and on the Company’s web site www.tornadotrucks.com. All amounts reported in this news release are in thousands ($000’s CAD) except per share amounts. Second Quarter 2022 Overview and Recent DevelopmentsRevenue of $13,362 in Q2/2022 increased 89% compared...

Alpine Income Property Trust Increases Quarterly Dividend By 1.9% and Declares Dividend For the Third Quarter 2022

Written by Customer Service on August 22, 2022. Posted in Dividend Reports And Estimates.

WINTER PARK, Fla., Aug. 22, 2022 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that its Board of Directors has authorized, and the Company has declared a quarterly cash dividend of $0.275 per share of common stock for the third quarter of 2022 (the “Common Stock Cash Dividend”), which represents a 1.9% increase as compared to the Company’s previous quarterly cash dividend of $0.27 per share of common stock. The Common Stock Cash Dividend represents a 7.8% year-over-year increase as compared to the Company’s third quarter 2021 common stock cash dividend and an annualized yield of approximately 6.0% based on the closing price of the common stock on August 19, 2022. The Common Stock Cash Dividend is payable on September 30, 2022 to stockholders of record as of the close of business...

CTO Realty Growth Increases Quarterly Dividend By 1.8% and Declares Dividends For the Third Quarter 2022

Written by Customer Service on August 22, 2022. Posted in Dividend Reports And Estimates.

WINTER PARK, Fla., Aug. 22, 2022 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) announced today that its Board of Directors has authorized, and the Company has declared a quarterly cash dividend of $0.38 per share of common stock for the third quarter of 2022 (the “Common Stock Cash Dividend”), which represents a 1.8% increase as compared to the Company’s previous quarterly cash dividend of $0.37333 per share of common stock. The Common Stock Cash Dividend is being increased to account for the Company’s strong year-to-date cash flow growth and the need to distribute a certain amount of taxable income to maintain its REIT tax status. The Common Stock Cash Dividend represents a 14.0% year-over-year increase as compared to the Company’s third quarter 2021 common stock cash dividend and an annualized...

Supplementary prospectus to £3,000,000,000 Euro Medium Term Note Programme

Written by Customer Service on August 22, 2022. Posted in Public Companies.

Issuer LEI: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the “Company” or “Issuer”) The Company announces today that a supplementary prospectus dated 22 August 2022 to the base prospectus dated 14 January 2022 (the “Base Prospectus“), as supplemented on 1 April 2022, in relation to the establishment of its £3,000,000,000 Euro Medium Term Note Programme (the “EMTN Programme”) has been approved by the Financial Conduct Authority and is available for viewing. To view the full document, paste the following URL into the address bar of your browser: https://www.osb.co.uk/investors/bond-investors/emtn-programme A copy of the EMTN Programme will also be submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism. OSB GROUP PLC Alastair Pate t:...

Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes

Written by Customer Service on August 22, 2022. Posted in Public Companies.

Bagsværd, Denmark, 22 August 2022 – Novo Nordisk today announced headline results from a phase 2 clinical trial with CagriSema, a once-weekly subcutaneous combination of semaglutide and a novel amylin analogue, cagrilintide. The trial investigated the efficacy and safety of a fixed dose combination of CagriSema (2.4 mg semaglutide and 2.4 mg cagrilintide) compared to the individual components semaglutide 2.4 mg and cagrilintide 2.4 mg, all administered once weekly, in 92 people with type 2 diabetes and overweight. People were equally randomised among the three treatment arms. In the trial, the mean baseline HbA1c was 8.4% and the mean baseline body weight was 106 kg. After 32 weeks of treatment, people treated with CagriSema achieved a numerically higher HbA1c reduction of 2.18%-points compared to a reduction of 1.79%-points for people...

Parsons to Present at Raymond James Diversified Industrials Conference

Written by Customer Service on August 22, 2022. Posted in Public Companies.

CENTREVILLE, Va., Aug. 22, 2022 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that Carey Smith, chair, president, and chief executive officer, and Matt Ofilos, chief financial officer, will present at the 2022 Raymond James Diversified Industrials Conference in New York City on Tuesday, August 23, 2022, at approximately 8:35 a.m. Eastern Time. This presentation will be available live via webcast on the investor relations section of Parsons’ website (https://investors.parsons.com/). A replay of the webcast also will be available on the website for 30 days. About Parsons Parsons (NYSE: PSN) is a leading disruptive technology provider in the national security and critical infrastructure markets, with capabilities across cybersecurity, missile defense, space, C5ISR, transportation, environmental remediation, and...

Day: August 22, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals